Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

48.81
Delayed Data
As of Jul 31
 +0.99 / +2.07%
Today’s Change
19.67
Today|||52-Week Range
51.99
+53.73%
Year-to-Date
No recent news for ACADIA Pharmaceuticals Inc.

Today’s Trading

Previous close47.82
Today’s open48.25
Day’s range47.76 - 49.70
Volume697,444
Average volume (3 months)1,036,789
Market cap$4.9B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-44.61%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book15.78

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...+5.11+4.41%
AKRXAkorn Inc-0.22-0.47%
NBIXNeurocrine Bioscienc...+0.10+0.20%
GRFSGrifols SA-0.45-1.37%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger G. Mills
Corporate headquarters
San Diego, California

Forecasts